The CHIRAN TEA/Folic acid supplement project
Not Applicable
- Conditions
- Health promotion
- Registration Number
- JPRN-UMIN000038301
- Lead Sponsor
- DHC Corporation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
- Subjects who have an inappropriate clinical history for efficacy and safety assessment in the study (such as drug abuse, alcoholism, and the disease of heart, liver, kidney, lungs, eye, blood etc) and who is taking any drugs. - Subjects judged to be inappropriate for the study by the investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Health related QO
- Secondary Outcome Measures
Name Time Method The compliance of dietary supplements. The prevalence of new-onset dementia, cerebral infarction and other diseases associated with high homocysteine and/or low folate. Changes in medical costs. The changes in plasma folic acid and homocysteine.